Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,524 | -111,325 | -68,101 | -19,498 | -81,177 |
| Depreciation Amortization | 15,351 | 11,502 | 7,634 | 3,715 | 12,855 |
| Accounts receivable | 4,269 | 5,698 | -7,830 | -19,730 | -16,340 |
| Accounts payable and accrued liabilities | 518 | 4,799 | 17 | -34 | -412 |
| Other Working Capital | 7,930 | 26,019 | 16,471 | -12,121 | -34,705 |
| Other Operating Activity | 8,432 | -1,306 | 14,557 | 24,020 | 46,696 |
| Operating Cash Flow | $-117,024 | $-64,613 | $-37,252 | $-23,648 | $-73,083 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,392 | -3,741 | -3,234 | -1,679 | -11,195 |
| Purchase Of Investment | -334,659 | -142,972 | -72,806 | -31,452 | -297,608 |
| Sale Of Investment | 258,651 | 206,418 | 107,363 | 69,377 | 269,467 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 25,000 |
| Investing Cash Flow | $-82,400 | $59,705 | $31,323 | $36,246 | $-14,336 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 241,262 |
| Debt Repayment | -5,945 | -5,376 | -3,517 | -1,723 | -142,687 |
| Common Stock Issued | 209,563 | 18,041 | 9,643 | 6,096 | 32,208 |
| Financing Cash Flow | $203,618 | $12,665 | $6,126 | $4,373 | $130,783 |
| Exchange Rate Effect | -124 | -32 | -91 | 8 | -159 |
| Beginning Cash Position | 55,570 | 55,570 | 55,570 | 55,570 | 12,365 |
| End Cash Position | 59,640 | 63,295 | 55,676 | 72,549 | 55,570 |
| Net Cash Flow | $4,070 | $7,725 | $106 | $16,979 | $43,205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,024 | -64,613 | -37,252 | -23,648 | -73,083 |
| Capital Expenditure | -6,392 | -3,741 | -3,234 | -1,679 | -11,195 |
| Free Cash Flow | -123,416 | -68,354 | -40,486 | -25,327 | -84,278 |